Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Massive study tracks how doctors really treat diabetes and heart disease

NCT ID NCT03549754

Knowledge-focused Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Sep 10, 2026 · Updated 6 times

Summary

This registry is collecting information from 35,000 adults with type 2 diabetes, high blood pressure, heart failure, and/or chronic kidney disease. Researchers want to see how these conditions are managed in everyday medical practice, what treatments people receive, and how often they need hospital care. The goal is to understand real-world care patterns and outcomes, not to test a new drug or treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 35,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2018

Expected to finish

Dec 2030

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adults with type 2 diabetes, Hypertension, Heart Failure and/or chronic kidney disease

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Being 18 years or older 2. Having type 2 diabetes, Hypertension, Heart Failure and/or chronic kidney disease 3. Providing written informed consent to participate in the registry Exclusion Criteria: 1. Having a life-threatening co-morbidity with life expectancy below 1 year 2. Participating in an interventional trial requiring informed consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic kidney disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

chronic kidney disease chronic renal failure syndrome heart failure hypertensive disorder type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic kidney disease Heart failure Hypertension Type 2 diabetes

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    76 sites in 20 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Research Site

    RECRUITING

    Fortaleza, Ceará, 60840-285, Brazil

  • Research Site

    RECRUITING

    Colatina, Espírito Santo (ES), 29707-035, Brazil

  • Research Site

    RECRUITING

    Salvador, Estado de Bahia, 40730-220, Brazil

  • Research Site

    RECRUITING

    Brasília, Federal District, 70673-623, Brazil

  • Research Site

    RECRUITING

    Poços de Caldas, Minas Gerais, 37706-106, Brazil

  • Research Site

    RECRUITING

    Campina Grande do Sul, Paraná, 83430-000, Brazil

  • Research Site

    RECRUITING

    Curitiba, Paraná, 80230-020, Brazil

  • Research Site

    RECRUITING

    Teresina, Piauí (PI), 64001-450, Brazil

  • Research Site

    RECRUITING

    Santa Cruz do Sul, Rio Grande Do Sul (RS), 96835-090, Brazil

  • Research Site

    RECRUITING

    Goiânia, State of Goias, 74453-200, Brazil

  • Research Site

    RECRUITING

    Joinville, State of Santa Catarina, 89204-248, Brazil

  • Research Site

    RECRUITING

    Bragança Paulista, São Paulo, 12916-542, Brazil

  • Research Site

    RECRUITING

    São Caetano do Sul, São Paulo, 09521-160, Brazil

  • Research Site

    RECRUITING

    São Paulo, 05403-000, Brazil

  • Research Site

    RECRUITING

    São Paulo, 05403-900, Brazil

  • Research Site

    RECRUITING

    Providencia, Santiago Metropolitan, 7500922, Chile

  • Research Site

    RECRUITING

    San José, Costa Rica

  • Research Site

    RECRUITING

    Abidjan, Côte d’Ivoire

  • Research Site

    RECRUITING

    Alexandria, Egypt

  • Research Site

    RECRUITING

    Cairo, Egypt

  • Research Site

    RECRUITING

    Giza, Egypt

  • Research Site

    RECRUITING

    Tbilisi, Georgia

  • Research Site

    RECRUITING

    Kumasi, Ghana

  • Research Site

    RECRUITING

    Wan Chai, Hong Kong

  • Research Site

    RECRUITING

    Ahmedabad, India

  • Research Site

    RECRUITING

    Kolkata, 700034, India

  • Research Site

    RECRUITING

    Mumbai, 400006, India

  • Research Site

    RECRUITING

    Sulaymaniyah, 46001, Iraq

  • Research Site

    RECRUITING

    Aktobe, 30019, Kazakhstan

  • Research Site

    RECRUITING

    Almaty, 50000, Kazakhstan

  • Research Site

    RECRUITING

    Almaty, 50006, Kazakhstan

  • Research Site

    RECRUITING

    Almaty, 50012, Kazakhstan

  • Research Site

    RECRUITING

    Almaty, 50054, Kazakhstan

  • Research Site

    RECRUITING

    Nairobi, 14497, Kenya

  • Research Site

    RECRUITING

    Kuala Lumpur, Malaysia

  • Research Site

    RECRUITING

    León, Guanajuato, 37549, Mexico

  • Research Site

    RECRUITING

    Iztapalapa, Mexico

  • Research Site

    RECRUITING

    Mexico City, 06720, Mexico

  • Research Site

    RECRUITING

    Mexico City, Mexico

  • Research Site

    RECRUITING

    México, 04530, Mexico

  • Research Site

    RECRUITING

    Enugu, 400001, Nigeria

  • Research Site

    RECRUITING

    Gwagwalada, 901002, Nigeria

  • Research Site

    RECRUITING

    Kano, 700233, Nigeria

  • Research Site

    NOT_YET_RECRUITING

    Bulacan, Philippines

  • Research Site

    RECRUITING

    Cebu City, Philippines

  • Research Site

    NOT_YET_RECRUITING

    Iloilo City, Philippines

  • Research Site

    NOT_YET_RECRUITING

    Laguna, Philippines

  • Research Site

    NOT_YET_RECRUITING

    Mandaluyong, Philippines

  • Research Site

    NOT_YET_RECRUITING

    Manila, Philippines

  • Research Site

    NOT_YET_RECRUITING

    Mindoro, Philippines

  • Research Site

    NOT_YET_RECRUITING

    Pampanga, Philippines

  • Research Site

    NOT_YET_RECRUITING

    Quezon City, Philippines

  • Research Site

    NOT_YET_RECRUITING

    Zamboanga City, Philippines

  • Research Site

    RECRUITING

    Florida, 1794, South Africa

  • Research Site

    RECRUITING

    Parow, 7505, South Africa

  • Research Site

    RECRUITING

    Umhlanga, 4319, South Africa

  • Research Site

    RECRUITING

    Umhlanga, 4320, South Africa

  • Research Site

    RECRUITING

    Changhua, 500209, Taiwan

  • Research Site

    RECRUITING

    Kaohsiung City, 81301, Taiwan

  • Research Site

    RECRUITING

    Niaosong, 83301, Taiwan

  • Research Site

    RECRUITING

    Taichung, 40447, Taiwan

  • Research Site

    RECRUITING

    Taichung, 40705, Taiwan

  • Research Site

    RECRUITING

    Taichung, Taiwan

  • Research Site

    RECRUITING

    Tainan, 704, Taiwan

  • Research Site

    RECRUITING

    Taipei, Taiwan

  • Research Site

    RECRUITING

    Taoyuan City, 33305, Taiwan

  • Research Site

    RECRUITING

    Dnipro, Dnipropetrovsk Oblast, 49005, Ukraine

  • Research Site

    RECRUITING

    Kharkiv, Kharkiv Oblast, 61039, Ukraine

  • Research Site

    RECRUITING

    Kharkiv, Kharkiv Oblast, Ukraine

  • Research Site

    RECRUITING

    Kyiv, Kyiv Oblast, 3039, Ukraine

  • Research Site

    RECRUITING

    Kyiv, Kyiv Oblast, 4050, Ukraine

  • Research Site

    RECRUITING

    Vinnytsia, Vinnytsia Oblast, 21000, Ukraine

  • Research Site

    RECRUITING

    Lutsk, Volyn Oblast, 43024, Ukraine

  • Research Site

    RECRUITING

    Uzhhorod, Zakarpattia Oblast, 88000, Ukraine

  • Research Site

    RECRUITING

    Zaporizhzhya, Zaporizhzhia Oblast, 69035, Ukraine

  • Research Site

    RECRUITING

    Sharjah city, United Arab Emirates

More trials for these conditions

Other studies related to the condition(s) this trial covers.